Free Trial

National Research Co. Plans Quarterly Dividend of $0.12 (NASDAQ:NRC)

National Research logo with Business Services background
Remove Ads

National Research Co. (NASDAQ:NRC - Get Free Report) announced a quarterly dividend on Monday, March 24th, RTT News reports. Stockholders of record on Friday, March 28th will be paid a dividend of 0.12 per share on Friday, April 11th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.72%. The ex-dividend date is Friday, March 28th.

National Research Trading Down 8.1 %

NASDAQ:NRC traded down $1.14 during mid-day trading on Friday, reaching $12.91. The company's stock had a trading volume of 64,677 shares, compared to its average volume of 90,124. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47. The stock has a market cap of $296.23 million, a P/E ratio of 12.30 and a beta of 0.47. The company's fifty day simple moving average is $15.99 and its two-hundred day simple moving average is $18.12. National Research has a twelve month low of $12.87 and a twelve month high of $39.98.

National Research (NASDAQ:NRC - Get Free Report) last announced its quarterly earnings data on Monday, January 27th. The company reported $0.28 earnings per share for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

About National Research

(Get Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

See Also

Dividend History for National Research (NASDAQ:NRC)

Should You Invest $1,000 in National Research Right Now?

Before you consider National Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.

While National Research currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads